medmix AG (MEDXZ.XC)
Cboe UK · CHF · Industrials · Specialty Industrial Machinery
CHF 10.48 (+0.00%) as of
Key statistics
- Market cap
- 427.79M
- EPS (TTM)
- 0.00
- Dividend yield
- 0.95%
- 52-week range
- 7.64 – 12.34
- Beta
- 0.77
- Revenue (TTM)
- 437M
- Profit margin
- 0.02%
- Volume
- 5.42k
About medmix AG
medmix AG designs, produces, and sells high-precision devices and services in Switzerland and internationally. It operates through the Healthcare, and Consumer and Industrial segments. The company offers dispensers, cartridges, mixers, tips, syringes, pen, and auto injectors for delivery of dental materials; delivery devices and mixing for bone repair and tissue treatment, which are used for prosthetics, restoratives, anesthetics, and aesthetics; the pen and auto injectors, which are used in fertility and growth hormone treatments, treatment of diabetes, osteoporosis, and other diseases; and the delivery and mixing devices, which are used by tissue banks and medical device OEMs. It also produces and markets dispensers, cartridges, and mixers for two-component adhesives and sealants for use in construction, transportation, electronics, infrastructure, and general industrial sectors; and micro-brushes and applicators for eyes, eyelashes, lips, and facial make-up. The company offers its products under the Mixpac, Transcodent, Qiaoyi, Cox, MK, Medmix, Haselmeier, and Geka brands. medmix AG was founded in 1922 and is based in Baar, Switzerland.
- Sector
- Industrials
- Industry
- Specialty Industrial Machinery
- Headquarters
- Baar, Switzerland
- Employees
- 2,587
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.